Are You or Someone You Know Living with Alzheimer’s Disease? Athira Pharma is Conducting Clinical Trials of fosgonimeton Open Label Extension Study for Participants Who Completed the LIFT-AD or ACT-AD Trial Click Here for More Information “ATH-1017 is a fast acting, novel approach that may have long lasting results”.